University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases, The Netherlands.
University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases, The Netherlands.
Chest. 2021 May;159(5):1833-1842. doi: 10.1016/j.chest.2020.12.007. Epub 2020 Dec 17.
Bronchoscopic lung volume reduction with one-way endobronchial valves is a guideline treatment option for patients with advanced emphysema that is supported by extensive scientific data. Patients limited by severe hyperinflation, with a suitable emphysema treatment target lobe and with absence of collateral ventilation, are the responders to this treatment. Detailed patient selection, a professional treatment performance, and dedicated follow up of the valve treatment, including management of complications, are key ingredients to success. This treatment does not stand alone; it especially requires extensive knowledge of COPD for which the most appropriate treatment is discussed in a multidisciplinary approach. We discuss the endobronchial valve treatment for emphysema and provide a guideline for patient selection, treatment guidance, and practice tools, based on our own experience and literature.
经支气管镜单向活瓣肺减容术是一种治疗晚期肺气肿的指南推荐方法,其疗效已得到广泛的科学数据支持。该疗法的适应证为严重过度充气、具有合适的肺气肿靶肺叶且不存在侧支通气的患者。详细的患者选择、专业的治疗操作以及对阀门治疗(包括并发症管理)的专门随访是取得成功的关键因素。这种治疗并不能独立存在;它尤其需要对 COPD 有广泛的了解,而最适合的治疗方法将在多学科方法中进行讨论。我们根据自己的经验和文献讨论了支气管内活瓣治疗肺气肿,并提供了患者选择、治疗指导和实践工具的指南。